Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.
Seung Tae KimSun Young KimJeeyun LeeSeong Hyeon YunHee Cheol KimWoo Yong LeeTae Won KimYong Sang HongSeok Byung LimJi Yeon BaekJae Hwan OhJoong Bae AhnSang Joon ShinSae-Won HanSeong Geun KimSeok Yun KangSun Jin SymDae Young ZangYeul Hong KimIn Sil ChoiJung Hun KangMin-Ji KimYoung Suk ParkPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
This study suggests that adding 3 months of oxaliplatin to 6 months of capecitabine could be considered an alternative adjuvant treatment for stage III CRC (ClinicalTrials.gov identifier: NCT01092481).